Search for Clinical Trial Results

Sponsored By

Prostatic Neoplasms, Castration-Resistant - 22 Studies Found

Status Study
COMPLETED Study Name: Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer
Condition: Prostatic Neoplasms, Castration-Resistant
Date: 2025-11-04
Interventions: Etrumadenant is an A2aR and A2bR antagonist
COMPLETED Study Name: Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases
Condition: Prostatic Neoplasms, Castration-Resistant
Date: 2025-11-04
Interventions: Xofigo treatment will be performed according to the product label in Japan under the routine clinical practice.
<<< Previous